NCT04728035View on ClinicalTrials.gov

Study of Irinotecan Liposome Injection in Patients With Advanced Breast Cance

PHASE1CompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

May 31, 2021

Primary Completion Date

June 5, 2023

Study Completion Date

June 5, 2024

Conditions
Advanced Breast Cancer
Interventions
DRUG

Irinotecan Liposome Injection

Irinotecan Liposome Injection

Trial Locations (1)

Unknown

Cancer Hosptial of CAMS, Beijing

Sponsors
All Listed Sponsors
lead

CSPC Ouyi Pharmaceutical Co., Ltd.

INDUSTRY

NCT04728035 - Study of Irinotecan Liposome Injection in Patients With Advanced Breast Cance | Biotech Hunter | Biotech Hunter